Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)
|
December 18, 2010
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules
Giulia Veronesi, Eva Szabo, Andrea Decensi, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 4, 2015
A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer
Matteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women
Andrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
Journal of the National Cancer Institute
|
August 29, 2025
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancer
Alessio Carbone, Martino Oliva, Matteo Puntoni, et al.
Nutrients
|
June 2, 2021
A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics
Matteo Lazzeroni, Federica Bellerba, Mariarosaria Calvello, et al.
Nutrients
|
January 28, 2021
Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and Adipokines
Davide Serrano, Chiara Pozzi, Silvia Guglietta, et al.
The Oncologist
|
March 7, 2009
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years
Aliana Guerrieri-Gonzaga, Edoardo Botteri, Nicole Rotmensz, et al.
Breast Cancer Research : BCR
|
June 22, 2013
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
Davide Serrano, Matteo Lazzeroni, Sara Gandini, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial
Valentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Genes
|
May 27, 2023
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
Mariarosaria Calvello, Monica Marabelli, Sara Gandini, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Cancer Prevention Research (Philadelphia, Pa.)
|
December 18, 2010
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules
Giulia Veronesi, Eva Szabo, Andrea Decensi, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 4, 2015
A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer
Matteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women
Andrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
Journal of the National Cancer Institute
|
August 29, 2025
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancer
Alessio Carbone, Martino Oliva, Matteo Puntoni, et al.
Nutrients
|
June 2, 2021
A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics
Matteo Lazzeroni, Federica Bellerba, Mariarosaria Calvello, et al.
Nutrients
|
January 28, 2021
Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and Adipokines
Davide Serrano, Chiara Pozzi, Silvia Guglietta, et al.
The Oncologist
|
March 7, 2009
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years
Aliana Guerrieri-Gonzaga, Edoardo Botteri, Nicole Rotmensz, et al.
Breast Cancer Research : BCR
|
June 22, 2013
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
Davide Serrano, Matteo Lazzeroni, Sara Gandini, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial
Valentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Genes
|
May 27, 2023
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
Mariarosaria Calvello, Monica Marabelli, Sara Gandini, et al.
Page
of 9